Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

unknown1
Active, not recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

unknown133%
active_not_recruiting133%
enrolling_by_invitation133%

Recent Activity

1 active trials
Showing 3 of 3
enrolling_by_invitationnot_applicable

Optical Coherence Tomography in Acute Vessel Evaluation

NCT07422688
active_not_recruitingnot_applicable

The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER)

NCT03171311
unknownnot_applicable

Augmented-Reality CTA Plus Angiography vs Angiography Alone for Guiding PCI in Coronary Lesions - Randomized Study

NCT03531424

Clinical Trials (3)

Showing 3 of 3 trials
NCT07422688Not Applicable

Optical Coherence Tomography in Acute Vessel Evaluation

Enrolling By Invitation
NCT03171311Not Applicable

The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER)

Active Not Recruiting
NCT03531424Not Applicable

Augmented-Reality CTA Plus Angiography vs Angiography Alone for Guiding PCI in Coronary Lesions - Randomized Study

Unknown

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3